Autres langues Merck & Co., Inc.

Actions

MRK

US58933Y1055

Marché Fermé - Nyse Autres places de cotation 22:00:02 06/06/2024			Varia. 5j.	Varia. 1 janv.
130,5 ^USD	+0,83 %		+4,81 %	+19,72 %

05/06	MERCK & CO., INC. : HSBC conserve son opinion neutre	ZM
04/06	Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference	05/06
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06
Merck : résultat prometteur dans le soin du mélanome	03/06
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial	03/06
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival	03/06
Moderna & Merck Announces 3-Year Data for mRNA-4157 in Combination with KEYTRUDA (Pembrolizumab)	03/06
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up	03/06
Immutep, Merck Collaborate on Trial for Lung Cancer Therapy	03/06
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival	31/05
Sector Update: Health Care	31/05
Declaration of Voting Results by Merck & Co	30/05
Declaration of Voting Results by Merck & Co	30/05
Declaration of Voting Results by Merck & Co	30/05
Declaration of Voting Results by Merck & Co	30/05
US Equities Markets Close Lower Thursday After Q1 Economic Growth Found to be Slower Than Projected	30/05
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar	30/05
Summit Therapeutics Shares Triple After Drug Candidate Data	30/05
Summit Therapeutics cancer therapy succeeds in late-stage China study	30/05
Anaveon announces IND approval of ANV600-001 Phase I/II clinical study	30/05
FDA Grants Priority Review to Merck's Application for KEYTRUDA plus Chemotherapy as First-Line Treatment of Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma	30/05

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Merck & Co., Inc. : Une vache à lait qui cache des vedettes

Le 11 juillet 2022 à 11:12